| Publication | Date of Publication | Type |
|---|
| A calibrated power prior approach to borrow information from historical data with application to biosimilar clinical trials | 2024-11-29 | Paper |
| Erratum to: ``Bayesian optimal interval designs for phase I clinical trials | 2024-11-27 | Paper |
| gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points | 2024-11-21 | Paper |
| A dose finding design for seizure reduction in neonates | 2024-11-21 | Paper |
| BLAST: Bayesian latent subgroup design for basket trials accounting for patient heterogeneity | 2024-11-20 | Paper |
| Bayesian optimal interval designs for phase I clinical trials | 2024-11-14 | Paper |
| A Bayesian dose finding design for oncology clinical trials of combinational biological agents | 2024-11-14 | Paper |
| Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification | 2024-11-14 | Paper |
| A dose-schedule finding design for phase I-II clinical trials | 2024-11-14 | Paper |
| A Bayesian dose finding design for clinical trials combining a cytotoxic agent with a molecularly targeted agent | 2024-11-14 | Paper |
| Optimal marker-adaptive designs for targeted therapy based on imperfectly measured biomarkers | 2024-11-14 | Paper |
| Estimating progression-free survival in paediatric brain tumour patients when some progression statuses are unknown | 2024-11-13 | Paper |
| Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies | 2024-10-30 | Paper |
| A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies | 2024-10-29 | Paper |
| TITE-BOIN12: a Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy | 2024-10-29 | Paper |
| Hybrid design evaluating new biomarkers when there is an existing screening test | 2024-10-29 | Paper |
| uTPI: a utility-based toxicity probability interval design for phase I/II dose-finding trials | 2024-10-29 | Paper |
| Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS) | 2024-10-29 | Paper |
| A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison | 2024-10-28 | Paper |
| A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints | 2024-10-28 | Paper |
| ComPAS: a Bayesian drug combination platform trial design with adaptive shrinkage | 2024-10-28 | Paper |
| A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications | 2024-10-22 | Paper |
| A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multiregion gene expression sequencing | 2024-10-09 | Paper |
| Design and sample size determination for multiple-dose randomized phase II trials for dose optimization | 2024-10-08 | Paper |
| SAM: self-adapting mixture prior to dynamically borrow information from historical data in clinical trials | 2024-08-19 | Paper |
| DROID: dose-ranging approach to optimizing dose in oncology drug development | 2024-08-19 | Paper |
| Adaptive hybrid control design for comparative clinical trials with historical control data | 2024-07-22 | Paper |
| A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints | 2024-06-23 | Paper |
| Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers | 2023-10-30 | Paper |
| Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials | 2022-10-10 | Paper |
| Social network mediation analysis: a latent space approach | 2021-12-16 | Paper |
| A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes | 2021-12-06 | Paper |
| BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons | 2021-03-30 | Paper |
| An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes | 2020-10-26 | Paper |
| FMEM: Functional Mixed Effects Models for Longitudinal Functional Responses | 2019-11-19 | Paper |
| Latent class dynamic mediation model with application to smoking cessation data | 2019-10-25 | Paper |
| Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome | 2019-08-27 | Paper |
| Piezoelectric-sensitive mode of Lamb wave in one-dimensional piezoelectric phononic crystal plate | 2019-06-05 | Paper |
| Local polynomial regression for symmetric positive definite matrices | 2019-05-09 | Paper |
| Model-free scoring system for risk prediction with application to hepatocellular carcinoma study | 2019-03-13 | Paper |
| A utility‐based design for randomized comparative trials with ordinal outcomes and prognostic subgroups | 2019-03-13 | Paper |
| A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes | 2018-12-04 | Paper |
| A Bayesian Phase I/II Trial Design for Immunotherapy | 2018-12-04 | Paper |
| https://portal.mardi4nfdi.de/entity/Q4642533 | 2018-05-23 | Paper |
| A Bayesian phase I/II clinical trial design in the presence of informative dropouts | 2018-05-08 | Paper |
| https://portal.mardi4nfdi.de/entity/Q5371734 | 2017-10-20 | Paper |
| Rate-adaptive Bayesian independent component analysis | 2017-01-11 | Paper |
| A Bayesian hierarchical spatial model for dental caries assessment using non-Gaussian Markov random fields | 2016-09-09 | Paper |
| Bayesian dose finding for combined drugs with discrete and continuous doses | 2016-02-05 | Paper |
| A direct method to evaluate the time‐dependent predictive accuracy for biomarkers | 2016-01-11 | Paper |
| Bayesian analysis for exponential random graph models using the adaptive exchange sampler | 2015-12-10 | Paper |
| Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity | 2015-10-15 | Paper |
| https://portal.mardi4nfdi.de/entity/Q5260439 | 2015-06-29 | Paper |
| Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials | 2015-06-10 | Paper |
| https://portal.mardi4nfdi.de/entity/Q5497590 | 2015-02-11 | Paper |
| The empirical Bayes test problem for the parameter of Cox models with rounded data | 2014-11-03 | Paper |
| Evaluation of image registration spatial accuracy using a Bayesian hierarchical model | 2014-07-22 | Paper |
| https://portal.mardi4nfdi.de/entity/Q4980415 | 2014-06-30 | Paper |
| Bayesian Latent‐Class Mixed‐Effect Hybrid Models for Dyadic Longitudinal Data with Non‐Ignorable Dropouts | 2014-04-08 | Paper |
| Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity | 2014-03-28 | Paper |
| https://portal.mardi4nfdi.de/entity/Q5399090 | 2014-02-28 | Paper |
| Empirical Bayes test problem of the parameter for the continuous one-parameter exponential family | 2013-11-19 | Paper |
| Varying coefficient model for modeling diffusion tensors along white matter tracts | 2013-06-06 | Paper |
| Bayesian modeling longitudinal dyadic data with nonignorable dropout, with application to a breast cancer study | 2012-08-01 | Paper |
| Goodness-of-fit diagnostics for Bayesian hierarchical models | 2012-06-27 | Paper |
| Dose-response curve estimation: a semiparametric mixture approach | 2012-06-20 | Paper |
| Robust EM Continual Reassessment Method in Oncology Dose Finding | 2012-01-18 | Paper |
| Bayesian phase I/II adaptively randomized oncology trials with combined drugs | 2011-10-21 | Paper |
| Bayesian estimation of semiparametric nonlinear dynamic factor analysis models using the Dirichlet process prior | 2011-07-27 | Paper |
| Bayesian Quantile Regression for Longitudinal Studies with Nonignorable Missing Data | 2010-05-26 | Paper |
| A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents | 2009-10-19 | Paper |
| Mixed‐Effect Hybrid Models for Longitudinal Data with Nonignorable Dropout | 2009-06-30 | Paper |
| Meta‐Analysis of Studies with Missing Data | 2009-06-30 | Paper |
| Joint Regression Analysis of Correlated Data Using Gaussian Copulas | 2009-04-23 | Paper |
| https://portal.mardi4nfdi.de/entity/Q3534843 | 2008-11-05 | Paper |
| The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach | 2008-03-19 | Paper |
| Model-Based Estimates of the Finite Population Mean for Two-Stage Cluster Samples With Unit Non-Response | 2007-09-07 | Paper |
